Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults

Neurobiology of Aging

Volumn 33, Issue 12, 2012, Pages 2723-2732

  Alexander, Gene E ^a,b,c   Bergfield, Kaitlin L ^b,c   Chen, Kewei ^c,d,e   Reiman, Eric M ^c,d,f,g   Hanson, Krista D ^a,b,c   Lin, Lan ^a,b,c   Bandy, Daniel ^c,d   Caselli, Richard J ^c,h   Moeller, James R ⁱ  

^a University of Arizona   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c ARIZONA ALZHEIMER S CONSORTIUM   (United States)

^d BANNER ALZHEIMER S INSTITUTE   (United States)

^e ARIZONA STATE UNIVERSITY   (United States)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^g TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^h MAYO CLINIC   (United States)

ⁱ NONE   (United States)

Author keywords

Apolipoprotein E; Gray matter volume; Late onset Alzheimer's disease; Magnetic resonance imaging; Multivariate analysis; Voxel based morphometry

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN MAPPING; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; COMPARATIVE ANATOMY; CONTROLLED STUDY; FEMALE; FUSIFORM GYRUS; GENETIC ASSOCIATION; GENETIC RISK; GRAY MATTER; HIPPOCAMPUS; HUMAN; MALE; NEUROANATOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; VOXEL BASED MORPHOMETRY;

ADULT; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; BRAIN; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; REGRESSION ANALYSIS;

EID: 84866759212     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.01.014     Document Type: Article

References (69)

1. Alexander G.E., Chen K., Aschenbrenner M., Merkley T.L., Santerre-Lemmon L.E., Shamy J.L., Skaggs W.E., Buonocore M.H., Rapp P.R., Barnes C.A. Age-related regional network of magnetic resonance imaging gray matter in the rhesus macaque. J. Neurosci 2008, 28:2710-2718.
2. Alexander G.E., Chen K., Merkley T.L., Reiman E.M., Caselli R.J., Aschenbrenner M., Lewis D.J., Pietrini P., Teipel S.J., Hampel H., Rapoport S.I., Moeller J.R. Regional network of magnetic resonance imaging gray matter volume in healthy aging. Neuroreport 2006, 17:951-956.
3. Alexander G.E., Chen K., Pietrini P., Rapoport S.I., Reiman E.M. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies. Am. J. Psychiatry 2002, 159:738-755.
4. Alexander G.E., Furey M.L., Grady C.L., Pietrini P., Brady D.R., Mentis M.J., Schapiro M.B. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. Am. J. Psychiatry 1997, 154:165-172.
5. Alexander G.E., Mentis M.J., Van Horn J.D., Grady C.L., Berman K.F., Furey M.L., Pietrini P., Schapiro M.B., Rapoport S.I., Moeller J.R. Individual differences in PET activation of object perception and attention systems predict face matching accuracy. Neuroreport 1999, 10:1965-1971.
6. Alexander G.E., Moeller J.R. Application of the Scaled Subprofile Model to functional imaging in neuropsychiatric disorders: a principal component approach to modeling regional patterns of brain function in disease. Hum. Brain Mapp 1994, 2:79-94.
7. Ashburner J. A fast diffeomorphic image registration algorithm. NeuroImage 2007, 38:95-113.
8. Ashburner J., Friston K.J. Voxel-based morphometry-the methods. NeuroImagePsychiatry Res 2000, 11:805-821. 10.1016/S1053-8119(00)91734-8.
9. Ashburner J., Friston K.J. Computing average shaped tissue probability templates. NeuroImage 2009, 45:333-341.
10. Basso M., Yang J., Warren L., MacAvoy M.G., Varma P., Bronen R.A., van Dyck C.H. Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease. Psychiatry Res 2006, 146:251-261.
11. Benton A.L., Hamsher Kde S. Multilingual Aphasia Examination 1976, University of Iowa, Iowa City, IA.
12. Bergfield K.L., Hanson K.D., Chen K., Teipel S.J., Hampel H., Rapoport S.I., Moeller J.R., Alexander G.E. Age-related networks of regional covariance in MRI gray matter: reproducible multivariate patterns in healthy aging. NeuroImage 2010, 49:1750-1759.
13. Bookheimer S.Y., Strojwas M.H., Cohen M.S., Saunders A.M., Pericak-Vance M.A., Mazziotta J.C., Small G.W. Patterns of brain activation in people at risk for Alzheimer's disease. N. Engl. J. Med 2000, 343:450-456.
14. Brickman A.M., Habeck C., Ramos M.A., Scarmeas N., Stern Y. A forward application of age associated gray and white matter networks. Hum. Brain Mapp 2008, 29:1139-1146.
15. Brickman A.M., Habeck C., Zarahn E., Flynn J., Stern Y. Structural MRI covariance patterns associated with normal aging and neuropsychological functioning. Neurobiol. Aging 2007, 28:284-295.
16. Burggren A.C., Zeineh M.M., Ekstrom A.D., Braskie M.N., Thompson P.M., Small G.W., Bookheimer S.Y. Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. NeuroImage 2008, 41:1177-1183.
17. Burnham K.P., Anderson D. Model Selection and Multimodel Inference 2002, Springer Verlag, New York, NY.
18. Buschke H. Selective reminding for analysis of memory and learning. J. Verbal Learn. Verbal Behav 1973, 12:543-550. 10.1016/S0022-5371(73)80034-9.
19. Caselli R.J., Dueck A.C., Osborne D., Sabbagh M.N., Connor D.J., Ahern G.L., Baxter L.C., Rapcsak S.Z., Shi J., Woodruff B.K., Locke D.E., Snyder C.H., Alexander G.E., Rademakers R., Reiman E.M. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N. Engl. J. Med 2009, 361:255-263.
20. Caselli R.J., Hentz J.G., Osborne D., Graff-Radford N.R., Barbieri C.J., Alexander G.E., Hall G.R., Reiman E.M., Hardy J., Saunders A.M. Apolipoprotein E and intellectual achievement. J. Am. Geriatr. Soc 2002, 50:49-54.
21. Caselli R.J., Reiman E.M., Osborne D., Hentz J.G., Baxter L.C., Hernandez J.L., Alexander G.E. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE ε4 allele. Neurology 2004, 62:1990-1995.
22. de Leon M.J., Ferris S.H., George A.E., Reisberg B., Christman D.R., Kricheff I.I., Wolf A.P. Computed tomography and positron emission transaxial evaluations of normal aging and Alzheimer's disease. J. Cereb. Blood Flow Metab 1983, 3:391-394.
23. den Heijer T., Oudkerk M., Launer L.J., van Duijn C.M., Hofman A., Breteler M.M.B. Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology 2002, 59:746-748.
24. Dennis N.A., Browndyke J.N., Stokes J., Need A., Burke J.R., Welsh-Bohmer K.A., Cabeza R. Temporal lobe functional activity and connectivity in young adult APOE ε4 carriers. Alzheimers Dement 2010, 6:303-311.
25. Dodrill C.B. A neuropsychological battery for epilepsy. Epilepsia 1978, 19:611-623.
26. Duara R., Grady C.L., Haxby J.V., Sundaram M., Cutler N.R., Heston L., Moore A.M., Schlageter N.L., Larson S., Rapoport S.I. Positron emission tomography in Alzheimer's disease. Neurology 1986, 36:879-887.
27. Efron B., Tibshirani R.J. An Introduction to the Bootstrap 1994, CRC Press, New York, NY.
28. Eidelberg D., Moeller J.R., Ishikawa T., Dhawan V., Spetsieris P., Chaly T., Belakhlef A., Mandel F., Przedborski S., Fahn S. Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography. Neurology 1995, 45:1995-2004.
29. Espeseth T., Westlye L.T., Fjell A.M., Walhovd K.B., Rootwelt H., Reinvang I. Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E ε4. Neurobiol. Aging 2008, 29:329-340.
30. Filippini N., Macintosh B.J., Hough M.G., Goodwin G.M., Frisoni G.B., Smith S.M., Matthews P.M., Beckmann C.F., Mackay C.E. Distinct patterns of brain activity in young carriers of the APOE-ε4 allele. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7209-7214.
31. Fjell A.M., Westlye L.T., Amlien I., Espeseth T., Reinvang I., Raz N., Agartz I., Salat D.H., Greve D.N., Fischl B., Dale A.M., Walhovd K.B. High consistency of regional cortical thinning in aging across multiple samples. Cereb. Cortex 2009, 19:2001-2012.
32. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res 1975, 12:189-198. 10.1016/0022-3956(75)90026-6.
33. Frackowiak R.S.J., Pozzill I.C., Legg N.J., DuBoulay G.H., Marshall J., Lenzi G.L., Jones T. Regional cerebral oxygen supply and utilization in dementia: a clinical and physiological study with oxygen-15 and positron emission tomography. Brain 1981, 104:753-778.
34. Good C.D., Johnstrude I.S., Ashburner J., Henson R.N.A., Friston K.J., Frackowiak R.S.J. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage 2001, 14:21-36.
35. Grady C.L. Cognitive neuroscience of aging. Ann. N. Y. Acad. Sci 2008, 1124:127-144. [PubMed: 18400928]. 10.1196/annals.1440.009.
36. Habeck C., Krakauer J.W., Ghez C., Sackeim H.A., Eidelberg D., Stern Y., Moeller J.R. A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural Comput 2005, 17:1602-1645.
37. Haxby J.V., Duara R., Grady C.L., Cutler N.R., Rapoport S.I. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. J. Cereb. Blood Flow Metab 1985, 5:193-200.
38. Hua X., Lee S., Yanovsky I., Leow A.D., Chou Y.Y., Ho A.J., Gutman B., Toga A.W., Jack C.R., Bernstein M.A., Reiman E.M., Harvey D.J., Kornak J., Schuff N., Alexander G.E., Weiner M.W., Thompson P.M. Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. NeuroImage 2009, 48:668-681. Alzheimer's Disease Neuroimaging Initiative.
39. Jack C.R., Petersen R.C., O'Brien P.C., Tangalos E.G. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992, 42:183-188.
40. Johnson S.C., Schmitz T.W., Trivedi M.A., Ries M.L., Torgerson B.M., Carlsson C.M., Asthana S., Hermann B.P., Sager M.A. The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J. Neurosci 2006, 26:6069-6076.
41. Kaplan E., Goodglass H., Weintraub S. Boston Naming Test, Experimental Version 1983, Boston Veterans Administration Center, Boston, MA.
42. Keene C.D., Cudaback E., Li X., Montine K.S., Montine T.J. Apolipoprotein E isoforms and regulation of the innate immune response in brain of patients with Alzheimer's disease. Curr. Opin. Neurobiol 2011, 21:1-9.
43. Klein A., Andersson J., Ardekani B.A., Ashburner J., Avants B., Chiang M.-C., Christensen G.E., Collins D.L., Gee J., Hellier P., Song J.H., Jenkinson M., Lepage C., Rueckert D., Thompson P., Vercauteren T., Woods R.P., Mann J.J., Parsey R.V. Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. NeuroImage 2009, 46:786-802.
44. Kok E., Haikonen S., Luoto T., Hubtala H., Goebeler S., Haapasalo H., Karhunen P.J. Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesion begins in middle age. Ann. Neurol 2009, 65:650-657.
45. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. Geriatric Psychiatry 1976, 77-121. Grune & Stratton, New York, NY. L. Bellack, T.B. Karasu (Eds.).
46. Moeller J.R., Strother S.C., Sidtis J.J., Rottenberg D.A. Scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic data. J. Cereb. Blood Flow Metab 1987, 7:649-658.
47. Mondadori C.R.A., de Quervain D.J.F., Buchmann A., Mustovic H., Wollmer M.A., Schmidt C.F., Boesiger P., Hock C., Nitsch R.M., Papassotiropoulos A., Henke K. Better memory and neural efficiency in young apolipoprotein E ε4 carriers. Cereb. Cortex 2007, 17:1934-1947.
48. Morris J.C., Roe C.M., Xiong C., Fagan A.M., Goate A.M., Holtzman D.M., Mintun M.A. APOE predicts amyloid-beta but not tau pathology in cognitively normal aging. Ann. Neurol 2010, 67:122-131.
49. Mueller S.G., Schuff N., Raptentsetsang S., Elman J., Weiner M.W. Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4T. NeuroImage 2008, 42:42-48.
50. Plassman B.L., Welsh-Bohmer K.A., Bigler E.D., Johnson S.C., Anderson C.V., Helms M.J., Saunders A.M., Breitner J.C. Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology 1997, 48:985-989.
51. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S., Thibodeau S.N., Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med 1996, 334:752-758.
52. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., Saunders A.M., Hardy J. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:284-289. [PubMed: 14688411]. 10.1073/pnas.2635903100.
53. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Dandy D., Osborne D., Saunders A.M., Hardy J. Correlations between apolipoprotein E ε4 gene dose and lower brain-imaging measurements of regional glucose metabolism. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:8299-8302.
54. Reiman E.M., Chen K., Liu X., Bandy D., Yu M., Lee W., Ayutyanont N., Keppler J., Reeder S.A., Langbaum J.B.S., Alexander G.E., Klunk W.E., Mathis C.A., Price J.C., Aizenstein H.J., DeKosky S.T., Caselli R.J. Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:6820-6825.
55. Reiman E.M., Uecker A., Caselli R.J., Lewis S., Bandy D., de Leon M.J., De Santi S., Convit A., Osborne D., Weaver A., Thibodeau S.N. Hippocampal volume in cognitively normal persons at genetic risk for Alzheimer's disease. Ann. Neurol 1998, 44:288-291.
56. Reitan R.M. Validity of the Trail Making Test as an indicator of organic brain damage. Percept. Mot. Skills 1958, 8:271-276.
57. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., Roses A.D. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43:1467-1472.
58. Schmidt H., Schmidt R., Fazekas F., Semmler J., Kapeller P., Reinhart B., Kostner G.M. ApoE 4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin. Genet 1996, 50:293-299.
59. Shaw P., Lerch J.P., Pruessner J.C., Taylor K.N., Rose A.B., Greenstein D., Clasen L., Evans A., Rapoport J.L., Giedd J.N. Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol 2007, 6:494-500. 10.1016/S1474-4422(07)70106-0.
60. Smith J.F., Chen K., Johnson S.C., Morrone-Strupinsky J., Reiman E.M., Nelson A., Moeller J.R., Alexander G.E. Network analysis of single-subject fMRI during a finger opposition task. NeuroImage 2006, 32:325-332.
61. Sperling R.A., Laviolette P.S., O'Keefe K., O'Brien J., Rentz D.M., Pihlajamak I.M., Marshall G., Hyman B.T., Selkoe D.J., Hedden T., Buckner R.L., Becker J.A., Johnson K.A. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 2009, 63:178-188.
62. Stern Y. Cognitive reserve. Neuropsychologia 2009, 47:2015-2028.
63. Stern Y., Alexander G.E., Prohovnik I., Stricks L., Link B., Lennon M.C., Mayeux R. Relationship between lifetime occupation and parietal flow: implications for a reserve against Alzheimer's disease pathology. Neurology 1995, 45:55-60.
64. Stern Y., Habeck C., Moeller J., Scarmeas N., Anderson K.E., Hilton H.J., Flynn J., Sackeim H., van Heertum R. Brain networks associated with cognitive reserve in healthy young and old adults. Cereb. Cortex 2005, 15:394-402.
65. Talairach J., Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain: 3-Dimensional Proportional System-an Approach to Cerebral Imaging 1988, Thieme Medical Publishers, New York, NY.
66. Trivedi M.A., Schmitz T.W., Ries M.L., Torgerson B.M., Sager M.A., Hermann B.P., Asthana S., Johnson S.C. Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study. B.M.C. Med 2006, 4:1.
67. Verghese P.B., Castellano J.M., Holtzman D.M. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 2011, 10:241-252. 10.1016/S1474-4422(10)70325-2.
68. Whitwell J.L., Przybelski S.A., Weigand S.D., Knopman D.S., Boeve B.F., Petersen R.C., Jack C.R. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 2007, 130:1777-1786.
69. Wishart H.A., Saykin A.J., McAllister T.W., Rabin L.A., McDonald B.C., Flashman L.A., Roth R.M., Mamourian A.C., Tsongalis G.J., Rhodes C.H. Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology 2006, 67:1221-1224. [PubMed: 17030756]. 10.1212/01.wnl.0000238079.00472.3a.